Cite
HARVARD Citation
Wang, J. et al. (2019). Durable blockade of PD-1 signaling links preclinical efficacy of sintilimab to its clinical benefit. MAbs. 11 (8), pp. 1443-1451. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wang, J. et al. (2019). Durable blockade of PD-1 signaling links preclinical efficacy of sintilimab to its clinical benefit. MAbs. 11 (8), pp. 1443-1451. [Online].